Information for the public
NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and the treatments they should receive. The information applies to people using the NHS in England and Wales.
This information explains the advice about the care and treatment of people with, or at risk of, delirium that is set out in NICE clinical guideline 103.
In March 2019 we removed olanzapine as a treatment for delirium.
Yes, if you are an adult (18 or over) with, or at risk of, delirium who is in hospital, long-term residential care or a nursing home.
No, if you:
are receiving end-of-life care
are under the influence of, or withdrawing from, drugs or alcohol
have delirium associated with drugs or alcohol.
NICE has published separate advice for the care of people with alcohol-related physical health problems, including delirium related to alcohol use (known as delirium tremens) (www.nice.org.uk/guidance/CG100).